Health Products Regulatory Authority of South Africa (Sahpra) announced that the antiparasitic drug ivermectin is no longer allowed to be prescribed to patients with Covid-19.
Sahpra immediately terminated the controlled compassionate use access program, saying there was no credible evidence that it helped treat Covid-19.
It states that since the program’s inception, there have been several developments regarding the evidence for the effectiveness of ivermectin.
“Further importation of non-registered ivermectin products will not be permitted and healthcare facilities will no longer be able to hold bulk stocks pending prescriptions for such non-registered ivermectin products.”
Sahpra also said that the results of two large clinical trials conducted in 2021 do not support the use of ivermectin for Covid-19 patients.
It states that two national health organizations have updated their recommendations and do not recommend the use of ivermectin in patients with Covid-19, except in the context of clinical trials.
The FDA has not authorized or approved ivermectin for the treatment or prevention of Covid-19 in humans or animals. Ivermectin has not been shown to be safe or effective for these indications. Taking large doses of ivermectin is dangerous, and even levels of ivermectin approved for human use can interact with other medications such as blood thinners.”
“You can also overdose on ivermectin, which can cause nausea, vomiting, diarrhea, hypotension (low blood pressure), allergic reactions (itching and hives), dizziness, ataxia (balance problems), seizures, coma, and even death.” — Sahpra . said.
Last January, Sahpra adopted the “Compassionate Use of Ivermectin Program Guidelines” under Section 21 of the Medicines and Related Substances Act, which permitted the use of ivermectin under Section 21 of the Act until more data was available. about the drug for the treatment of Covid. -19 symptoms.
Ivermectin is an antiparasitic agent used in various forms in both animals and humans.
Several studies published in the early days of the pandemic touted its benefits as a treatment for Covid-19.